To test this hypothesis we first established a transgenic mouse line that expresses human BID specifically in the thyroid, and then tested whether the overexpression of BID alone is sufficient for the development of autoimmune thyroiditis. The gene discussed is BID; the disease is autoimmune thyroid disease.